Caltech X Chromosome Gene Reactivation Patent EP3286310A1
Summary
The European Patent Office granted Patent EP3286310A1 to the California Institute of Technology covering methods for reactivating X chromosome genes. The invention relates to therapeutic and diagnostic applications in genetic medicine, classified under multiple IPC codes including C12N, C12Q, and A61K.
About this source
GovPing monitors EPO Patent Bulletin - Biotech (C12N) for new healthcare & life sciences regulatory changes. Every update since tracking began is archived, classified, and available as free RSS or email alerts — 47 changes logged to date.
What changed
The EPO published patent application EP3286310A1 for Caltech covering methods of reactivating X chromosome genes. The patent names Mitchell Guttman, Chun-Kan Chen, and Colleen A. McHugh as inventors. Designated states include all European Patent Convention contracting states.
Biotechnology and pharmaceutical companies developing gene therapy or genetic diagnostic technologies should review this patent when clearing new products or conducting freedom-to-operate analyses in European markets.
Archived snapshot
Apr 22, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
REACTIVATION OF X CHROMOSOME GENES
Publication EP3286310A1 Kind: A1 Apr 15, 2026
Applicants
California Institute of Technology
Inventors
GUTTMAN, Mitchell, CHEN, Chun-Kan, MCHUGH, Colleen A.
IPC Classifications
C12N 15/11 20060101AFI20181129BHEP C12Q 1/68 20180101ALI20181129BHEP G01N 33/50 20060101ALI20181129BHEP C07H 21/02 20060101ALI20181129BHEP A61K 31/7105 20060101ALI20181129BHEP A61K 38/17 20060101ALI20181129BHEP A61K 39/395 20060101ALI20181129BHEP
Designated States
AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR
Related changes
Get daily alerts for EPO Patent Bulletin - Biotech (C12N)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from EPO.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when EPO Patent Bulletin - Biotech (C12N) publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.